(RTTNews) - Quest Diagnostics (DGX) announced the launch of a new obstetrics laboratory test panel designed to enable physicians to screen all eligible pregnant people for hepatitis C with other ...

MELBOURNE, Australia, July 18, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and ...

SECAUCUS, NJ / ACCESSWIRE / October 17, 2022 / Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, recently announced the launch of a new obstetrics ...

Quest Diagnostics launched an obstetrics test panel for screening pregnant people for hepatitis C. The panel is designed to facilitate easy and reliable screening for hepatitis C with other lab tests ...

Sequenom, Inc., (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced the publication of a clinical ...

To provide the clinical experience, curricular programming, mentorship, research opportunities, and resources to produce physicians committed to providing comprehensive, compassionate, and ...

New test panel follows a Quest Diagnostics Health Trends® study with the CDC that revealed less than half of pregnant people are screened for hepatitis C as recommended under guidelines SECAUCUS, N.J.